{
  "id": 26065,
  "title": "AbbVie touts strong momentum for Skyrizi despite rising competition",
  "url": "https://urgent.news/2026/07/31/abbvie-touts-strong-momentum-for-skyrizi-despite-rising-competition",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-07-31T18:22:56.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/abbvie-touts-strong-momentum-for-skyrizi-despite-rising-competition/"
  },
  "original_language": "en",
  "account": null,
  "summary": "If AbbVie executives are bothered by growing threats to their immunology powerhouse, they aren't letting on. Earlier this year, analysts were pondering how the company’s blockbuster Skyrizi might fare against competition from ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}